Janssen, Alphapharm lay down swords in long-running battle over HIV drug patent
Intellectual Property 2019-05-06 12:03 pm By Cat Fredenburgh | Melbourne
Please login to bookmark Close

Drug maker Janssen will drop its long-running patent lawsuit against Alphapharm after the generic drug maker agreed to refrain from making products that allegedly infringe Janssen’s patents for its HIV drug Prezista.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au